info iconCurrently, the share price for Cipla Ltd. is delayed.

close icon
Cipla Ltd. Logo

Cipla Ltd.

--   ( -- %) 1D

  • Prev. Close
  • Upper Circuit
  • Lower Circuit

Analyst Recommendations For Cipla Ltd.

Info icon
As recommended by 9 analysts


Cipla Ltd.'s Info & Management

Cipla Limited is an Indian-origin multi-national company in the pharmaceutical sector. The company was established in 1935 and is headquartered in Mumbai, India. 

Business Segment

The company operates through two segments: 

  • Pharmaceuticals: is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API) 
  • New ventures: includes the operations of the company, consumer healthcare, Biosimilars and speciality businesses 
  • Product Portfolio: spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS) 

Geographical Presence

Its operations span across India, South Africa, and North America. The company has approximately 47 manufacturing sites around the world and produces 50+ dosage forms and 1,500+ generic products to cater to over 85 markets. 

Check Cipla share price for a comprehensive analysis with integrated tools for fundamental and technical analysis. Also, access the company profile, news, and events on Share.Market. Find detailed analysis of Cipla stock price to kickstart your investment journey now.

  • Company Secretary,Compliance Officer
    Rajendra Chopra
  • Executive Director,Managing Director,Chief Executive Officer
    Umang Vohra
  • Global Chief Financial Officer
    Mr Ashish Adukia
  • Global Chief People Officer
    Dr Raju Mistry
  • Chief Scientific Officer
    Mr Pradeep Bhadauria
  • Chief Technology Officer
    Ms Geena Malhotra

FAQs on Cipla Ltd.

What is the share price of Cipla Ltd.?

Cipla Ltd. share price is ₹1,396.80 as of April 12, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Cipla Ltd.?

The 52-week high and low of Cipla Ltd. is ₹1,518.95 and ₹896.30 respectively as of April 12, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Cipla Ltd.?

The trailing twelve month (TTM) PB ratio of Cipla Ltd. is 4.80 as of April 13, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Cipla Ltd.?

The Upper Circuit of Cipla Ltd. is ₹1,565. The Lower Circuit of Cipla Ltd. is ₹1,281.

What is the ROE of Cipla Ltd.?

Cipla Ltd. reported an ROE of 11.96% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Cipla Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Cipla Ltd., Promoter held 33.5%, the FII held 25.7%, DII held 24.3% and the public held 16.5% of the total shares.

How to buy Cipla Ltd. Share?

You can easily buy shares of Cipla Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Cipla Ltd.?

The fair value of Cipla Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer